射血分数保留型心力衰竭患者心肌代谢组学特征
该研究对38例HFpEF、30例HFrEF和20例非衰竭对照进行血浆和心内膜心肌活检的靶向代谢组学分析,发现尽管HFpEF患者肥胖和糖尿病比例更高,其心肌中中长链酰基肉碱、酮体、TCA循环中间产物和BCAA代谢物均低于对照,提示燃料利用不灵活。
要点
- HFpEF心肌脂肪酸氧化代谢物低于对照,尽管肥胖糖尿病更多。
- HFpEF心肌酮体、TCA中间产物和BCAA代谢物也降低。
- 血浆代谢物不能反映心肌代谢差异,提示需心肌活检评估。
核心结论
- HFpEF心肌表现为脂肪酸、酮体、TCA循环和BCAA代谢物降低,提示燃料利用不灵活。
研究设计与样本
- 获取HFpEF(n=38)、HFrEF(n=30)和非衰竭对照(n=20)的血浆和心内膜心肌活检,进行靶向定量代谢组学(心肌72种、血浆69种代谢物)并整合RNA测序数据。
主要发现
- HFpEF vs HFrEF:BMI 39.8 vs 26.1 kg/m2,糖尿病70% vs 30%,均P<0.0001。
- 心肌中长链酰基肉碱在两个心衰组均显著低于对照,而血浆水平无差异或高于对照。
- HFpEF心肌丙酮酸较高,琥珀酸和富马酸较低,BCAA最高但下游代谢物和基因较低。
- HFrEF心肌和血浆酮体水平升高,HFpEF无此变化。
临床怎么用
- HFpEF患者心肌代谢特征与肥胖糖尿病预期相反,提示燃料利用不灵活,血浆代谢物不能替代心肌评估。
局限性
- 样本量有限,为观察性研究,不能确立因果关系。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The human heart primarily metabolizes fatty acids, and this decreases as alternative fuel use rises in heart failure with reduced ejection fraction (HFrEF). Patients with severe obesity and diabetes are thought to have increased myocardial fatty acid metabolism, but whether this is found in those who also have heart failure with preserved ejection fraction (HFpEF) is unknown. METHODS: Plasma and endomyocardial biopsies were obtained from HFpEF (n=38), HFrEF (n=30), and nonfailing donor controls (n=20). Quantitative targeted metabolomics measured organic acids, amino acids, and acylcarnitines in myocardium (72 metabolites) and plasma (69 metabolites). The results were integrated with reported RNA sequencing data. Metabolomics were analyzed using agnostic clustering tools, Kruskal-Wallis test with Dunn test, and machine learning. RESULTS: Agnostic clustering of myocardial but not plasma metabolites separated disease groups. Despite more obesity and diabetes in HFpEF versus HFrEF (body mass index, 39.8 kg/m2 versus 26.1 kg/m2; diabetes, 70% versus 30%; both P<0.0001), medium- and long-chain acylcarnitines (mostly metabolites of fatty acid oxidation) were markedly lower in myocardium from both heart failure groups versus control. In contrast, plasma levels were no different or higher than control. Gene expression linked to fatty acid metabolism was generally lower in HFpEF versus control. Myocardial pyruvate was higher in HFpEF whereas the tricarboxylic acid cycle intermediates succinate and fumarate were lower, as were several genes controlling glucose metabolism. Non-branched-chain and branched-chain amino acids (BCAA) were highest in HFpEF myocardium, yet downstream BCAA metabolites and genes controlling BCAA metabolism were lower. Ketone levels were higher in myocardium and plasma of patients with HFrEF but not HFpEF. HFpEF metabolomic-derived subgroups were differentiated by only a few differences in BCAA metabolites. CONCLUSIONS: Despite marked obesity and diabetes, HFpEF myocardium exhibited lower fatty acid metabolites compared with HFrEF. Ketones and metabolites of the tricarboxylic acid cycle and BCAA were also lower in HFpEF, suggesting insufficient use of alternative fuels. These differences were not detectable in plasma and challenge conventional views of myocardial fuel use in HFpEF with marked diabetes and obesity and suggest substantial fuel inflexibility in this syndrome.
引用
- Hahn, Petucci, Kim, et al. Myocardial Metabolomics of Human Heart Failure With Preserved Ejection Fraction. Circulation. 2023. PMID: 36856044. doi:10.1161/CIRCULATIONAHA.122.061846
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。